Many OPOs, in collaboration with their regional transplant centers also have applications that support and facilitate living organ donation.. AOPO facilitates and works with living organ and tissue donation Currently, there are a lot more than 112,000 patients about the national organ transplant waiting list. These applicants often endure difficult yet necessary life-sustaining remedies while looking forward to potential organ matches. Nineteen people die every day while waiting, and the ones that are eventually transplanted can endure wait times that can extend anywhere from 5-9 years.Happy hair-styling!. ARCA biopharma receives technique patent for treatment with bucindolol predicated on genetic targeting ARCA biopharma, Inc. , a biopharmaceutical organization developing targeted treatments for cardiovascular diseases genetically, announced that the U today.S. Patent and Trademark Workplace has issued a patent on options for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a particular genotype – homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor. The patent entitled Methods for Treatment with Bucindolol Predicated on Genetic Targeting, provides intellectual real estate protection in the usa for this novel method of treating sufferers with bucindolol.